Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-04-18

FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TROKENDI XR (topiramate extended-release) from Supernus Pharmaceuticals, Inc. The action may include labeling up…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TROKENDI XR (TOPIRAMATE)

Snippet

SUPPL AP for TROKENDI XR (TOPIRAMATE)